We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.41B
AUM Growth
+$125M
Cap. Flow
-$6.29M
Cap. Flow %
-0.45%
Top 10 Hldgs %
35.33%
Holding
276
New
13
Increased
51
Reduced
96
Closed
8

Top Buys

Rank Stock Value
1
CLF icon
Cleveland-Cliffs
CLF
+$3.71M
2
XOM icon
ExxonMobil
XOM
+$2.57M
3
PANW icon
Palo Alto Networks
PANW
+$1.41M
4
NVO
Novo Nordisk
NVO
+$1.2M
5
URI icon
United Rentals
URI
+$909K

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$3.95M
2
VZ icon
Verizon
VZ
+$2.07M
3
NEE icon
NextEra Energy
NEE
+$1.38M
4
INTC icon
Intel
INTC
+$1.28M
5
IBM icon
IBM
IBM
+$1.12M

Sector Composition

Rank Sector Weight
1 Technology 23.1%
2 Healthcare 19.24%
3 Financials 13.15%
4 Industrials 11.27%
5 Communication Services 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITW icon
126
Illinois Tool Works
ITW
$84.5B
$1.16M 0.08%
4,699
– –
CL icon
127
Colgate-Palmolive
CL
$74.4B
$1.11M 0.08%
13,038
– –
OTIS icon
128
Otis Worldwide
OTIS
$28.2B
$1.1M 0.08%
12,632
-67
-0.5% -$5.61K
RDS.A
129
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.07M 0.08%
24,600
– –
FTV icon
130
Fortive
FTV
$18.6B
$1.04M 0.07%
18,058
– –
EQR icon
131
Equity Residential
EQR
$25.1B
$1.03M 0.07%
11,400
+2,400
+27% +$206K
GWW icon
132
W.W. Grainger
GWW
$60.2B
$1.03M 0.07%
1,979
– –
NUE icon
133
Nucor
NUE
$62.1B
$1.02M 0.07%
8,969
-175
-2% -$19.1K
PM icon
134
Philip Morris
PM
$295B
$1.02M 0.07%
10,730
– –
KNX icon
135
Knight Transportation
KNX
$11.4B
$1.01M 0.07%
16,650
-450
-3% -$25.5K
DOV icon
136
Dover
DOV
$28.4B
$968K 0.07%
5,332
– –
SYK icon
137
Stryker
SYK
$130B
$925K 0.07%
3,458
– –
HPQ icon
138
HP
HPQ
$27.5B
$913K 0.06%
24,250
– –
SLB icon
139
SLB Ltd
SLB
$75B
$876K 0.06%
29,257
-575
-2% -$18.1K
TT icon
140
Trane Technologies
TT
$106B
$873K 0.06%
4,320
-1,325
-23% -$249K
NVS icon
141
Novartis
NVS
$297B
$869K 0.06%
9,932
– –
SLRC icon
142
SLR Investment Corp
SLRC
$715M
$857K 0.06%
46,500
– –
CET
143
Central Securities Corp
CET
$1.65B
$848K 0.06%
19,028
– –
KEYS icon
144
Keysight
KEYS
$58.3B
$819K 0.06%
3,964
– –
ROP icon
145
Roper Technologies
ROP
$39.8B
$819K 0.06%
1,665
-55
-3% -$26.2K
ACN icon
146
Accenture
ACN
$108B
$806K 0.06%
1,945
-250
-11% -$91.1K
BKU icon
147
Bankunited
BKU
$3.36B
$805K 0.06%
19,015
– –
CMCSA icon
148
Comcast
CMCSA
$90B
$804K 0.06%
15,979
-1,066
-6% -$55.6K
COF icon
149
Capital One
COF
$134B
$791K 0.06%
5,455
– –
INTU icon
150
Intuit
INTU
$89B
$776K 0.06%
1,207
– –
4 5
6
7 8

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q4 2021 Portfolio in Review

As of Q4 2021, Neville Rodie & Shaw held 276 positions worth $1.41B, up 9.7% from $1.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Neville Rodie & Shaw's Q4 2021 filing shows 13 new, 51 increased, 96 reduced and 8 closed positions. Its largest new stake was Cleveland-Cliffs: 172,300 shares worth $3.75M. The largest sale was Acceleron Pharma, an estimated $3.95M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Neville Rodie & Shaw's largest Q4 2021 buy was Cleveland-Cliffs: 172,300 shares worth $3.75M.
  • Neville Rodie & Shaw added most to ExxonMobil in Q4 2021, an estimated $2.57M increase.
  • Neville Rodie & Shaw's biggest Q4 2021 reduction was Verizon, cutting an estimated $2.07M.
  • Neville Rodie & Shaw fully exited Acceleron Pharma in Q4 2021, selling an estimated $3.95M.
  • Neville Rodie & Shaw's ten largest holdings make up 35% of its $1.41B portfolio in Q4 2021.
  • Neville Rodie & Shaw opened 13 new positions and closed 8 in Q4 2021.
  • Neville Rodie & Shaw's portfolio value rose 9.7% quarter-over-quarter to $1.41B.

Based on Neville Rodie & Shaw's 13F filing for Q4 2021, filed 5 Jan 2022.